Jennifer Ross is Co-Founder and Co-CEO of Swoon, a zero-sugar beverage company reinventing classic drinks, and an entrepreneur focused on consumer brand innovation. Prior to founding Swoon, she worked in marketing and operations at Fanvision and began her career as an analyst at Goldman Sachs. She has been a longtime advocate for type 1 diabetes research, previously founding Rock the Cure, a fundraiser benefiting Breakthrough T1D (formerly JDRF). Diagnosed with type 1 diabetes at age six, her leadership and advocacy are deeply informed by personal experience. She holds a B.A. in Government from Dartmouth College and an M.B.A. from Harvard Business School. She serves as a member of the T1D Fund’s Board of Directors.

Chief Investment Officer, Chevy Chase Trust

Amy Raskin is a pioneer in global thematic investing and widely respected as a bold thought leader. As the Chief Investment Officer of Chevy Chase Trust since February 1, 2014, she has propelled the firm to a leadership position in thematic investing, a small, but rapidly growing approach to investing that MSCI  added to its universe of style categories last year.

Under her leadership, Chevy Chase Trust has outperformed its global benchmark in each of the last seven years, by an average of 5.5% after fees; it is in the top decile of managers for the last 3-, 5- and 10 years. Amy is also a monthly guest on CNBC.

Prior to joining Chevy Chase Trust, Amy was Senior Vice President at AllianceBernstein in New York, serving as Director of Research for Thematic Portfolios, Director of Research on Strategic Change, head of U.S. & Global Growth Equity Research and Chief Investment Officer of AB Venture Capital Fund. The Research on Strategic Change team published in-depth research papers on a wide range of thematic investment topics, such as broadband, China, hybrid vehicles, climate change and molecular medicine.

Earlier, she worked as an investment banker at Lehman Brothers and as a research analyst at Donaldson, Lufkin & Jenrette.

Amy graduated from the University of Pennsylvania’s School of Engineering and Applied Science with a Bachelor of Science in Engineering and is an active, long-term member of the Penn Association of Alumnae and the Trustees’ Council of Penn Women (TCPW). She currently serves as Co-Chair of the TCPW Development Committee, and sits on the School of Engineering and Applied Science’s Technical Advisory Board. Her most recent commitment is to funding and supporting research on Type 1 diabetes, which her younger son was diagnosed with in mid-2020.